Literature DB >> 9242342

Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer.

T Nishida1, K Nakao, M Hamaji, W Kamiike, K Kurozumi, H Matsuda.   

Abstract

OBJECTIVE: This study was undertaken to determine whether the recurrent laryngeal nerve involved in differentiated thyroid carcinoma could be preserved. SUMMARY BACKGROUND DATA: Few investigations have provided definitive results concerning preservation of the recurrent laryngeal nerve involved in thyroid cancer. Complete excision with resection of the recurrent laryngeal nerve reportedly did not improve survival over incomplete excision in differentiated thyroid carcinoma.
METHODS: A retrospective study was performed with the medical records of 50 patients with differentiated carcinoma and preoperative normal vocal cord function to investigate outcomes of recurrent laryngeal nerve preservation including local recurrence, prognosis, and postoperative vocal cord function. The recurrent laryngeal nerves on 1 or both sides were preserved in 23 patients (the preserved group), whereas the involved recurrent laryngeal nerve of the other 27 patients was resected (the resected group).
RESULTS: Backgrounds of patients were similar between the resected and preserved groups. The number of patients with recurrences in each group was similar, and incidence of local, regional, and distant metastatic recurrences were not different between the groups. Postoperative overall survival of the preserved group was similar to that of the resected group (p = 0.1208). More than 60% of patients or of nerve at risk in the preserved group restored normal vocal cord function within 6 months. Some functional vocal cord movement was recognized in 80% of patients or of nerve at risk. All patients in the resected group including patients with nerve anastomosis showed permanent paralysis of the ipsilateral vocal cord.
CONCLUSIONS: These results suggested that the recurrent laryngeal nerve, even if infiltrated by differentiated thyroid cancer, is worthwhile to preserve for maintenance of postoperative vocal cord function without affecting the incidence of local recurrence or prognosis.

Entities:  

Mesh:

Year:  1997        PMID: 9242342      PMCID: PMC1190911          DOI: 10.1097/00000658-199707000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

Review 1.  Surgery in the treatment of thyroid cancer.

Authors:  M J Demeure; O H Clark
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

Review 2.  Repair of the recurrent laryngeal nerve.

Authors:  R L Crumley
Journal:  Otolaryngol Clin North Am       Date:  1990-06       Impact factor: 3.346

3.  Benign disease of the thyroid gland and vocal cord paralysis.

Authors:  R G Rueger
Journal:  Laryngoscope       Date:  1974-06       Impact factor: 3.325

4.  Natural history, treatment, and course of papillary thyroid carcinoma.

Authors:  L J DeGroot; E L Kaplan; M McCormick; F H Straus
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

5.  Thyroid carcinoma invading the upper aerodigestive system.

Authors:  T V McCaffrey; R J Lipton
Journal:  Laryngoscope       Date:  1990-08       Impact factor: 3.325

6.  Resectional management of thyroid carcinoma invading the airway.

Authors:  H C Grillo; H C Suen; D J Mathisen; J C Wain
Journal:  Ann Thorac Surg       Date:  1992-07       Impact factor: 4.330

7.  Improvement of vocal cord paresis after thyroidectomy.

Authors:  A R McCall; R Ott; H Jarosz; A M Lawrence; E Paloyan
Journal:  Am Surg       Date:  1987-07       Impact factor: 0.688

8.  Surgical treatment of advanced thyroid carcinoma invading the trachea.

Authors:  T Ishihara; K Kobayashi; K Kikuchi; R Kato; M Kawamura; K Ito
Journal:  J Thorac Cardiovasc Surg       Date:  1991-11       Impact factor: 5.209

9.  Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients.

Authors:  W J Simpson; S E McKinney; J S Carruthers; M K Gospodarowicz; S B Sutcliffe; T Panzarella
Journal:  Am J Med       Date:  1987-09       Impact factor: 4.965

Review 10.  Radioiodine therapy for thyroid cancer.

Authors:  D C Sweeney; G S Johnston
Journal:  Endocrinol Metab Clin North Am       Date:  1995-12       Impact factor: 4.741

View more
  20 in total

1.  A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.

Authors:  Muneki Hotomi; Iwao Sugitani; Kazuhisa Toda; Kazuyoshi Kawabata; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  The importance of preoperative laryngeal examination before thyroidectomy and the usefulness of a voice questionnaire in screening.

Authors:  Inn-Chul Nam; Ja-Sung Bae; Mi-Ran Shim; Yeon-Shin Hwang; Min-Sik Kim; Dong-Il Sun
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Phonatory function in patients with well-differentiated thyroid carcinoma following meticulous resection of tumors adhering to the recurrent laryngeal nerve.

Authors:  Satoru Miyamaru; Yoshihiko Kumai; Daizo Murakami; Narihiro Kodama; Takumi Miyamoto; Eiji Yumoto; Yorihisa Orita
Journal:  Int J Clin Oncol       Date:  2019-06-24       Impact factor: 3.402

4.  Segmental tracheal resection for invasive differentiated thyroid carcinoma. Our experience in eight cases.

Authors:  Claudio Mossetti; Nicola Palestini; Maria Cristina Bruna; Michele Camandona; Milena Freddi; Alberto Oliaro; Guido Gasparri
Journal:  Langenbecks Arch Surg       Date:  2013-12       Impact factor: 3.445

5.  Papillary thyroid cancer in a gravid woman.

Authors:  Darrin V Bann; Neerav Goyal; David Goldenberg
Journal:  Ear Nose Throat J       Date:  2014-07       Impact factor: 1.697

Review 6.  Management of Invasive Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Ricard Simo; Kate Newbold; Alessandra Rinaldo; Carlos Suarez; Luiz P Kowalski; Carl Silver; Jatin P Shah; Alfio Ferlito
Journal:  Thyroid       Date:  2016-08-23       Impact factor: 6.568

7.  External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society.

Authors:  Ana P Kiess; Nishant Agrawal; James D Brierley; Umamaheswar Duvvuri; Robert L Ferris; Eric Genden; Richard J Wong; R Michael Tuttle; Nancy Y Lee; Gregory W Randolph
Journal:  Head Neck       Date:  2015-12-30       Impact factor: 3.147

8.  Operative management of locally advanced, differentiated thyroid cancer.

Authors:  Laura Y Wang; Iain J Nixon; Snehal G Patel; Frank L Palmer; R Michael Tuttle; Ashok Shaha; Jatin P Shah; Ian Ganly
Journal:  Surgery       Date:  2016-06-11       Impact factor: 3.982

9.  Papillary thyroid carcinoma with exclusive involvement of a functioning recurrent laryngeal nerve may be treated with shaving technique.

Authors:  Hyoung Shin Lee; Sung Won Kim; Taejung Park; Gi Yun Nam; Jong Chul Hong; Kang Dae Lee
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

Review 10.  Invasive thyroid cancer: management of the trachea and esophagus.

Authors:  Daniel L Price; Richard J Wong; Gregory W Randolph
Journal:  Otolaryngol Clin North Am       Date:  2008-12       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.